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1. Introduction 
Genital warts are still thought to be a benign cosmetic problem despite increasing evidence 
that they may harbour high-grade intra-epithelial neoplasia (IN). We have previously 
published high rates of high-grade IN in surgically excised warts from December 1995 to 
December 2004 in a retrospective review of 115 men and 38 women, 29 of whom had HIV 
infection. The rates of IN were 78% (52% high-grade) in men with HIV, and 33% (20% high-
grade) in men without HIV. In women the IN rate was 8.3% (2.8% high-grade).(McCloskey 
et al. 2007)  Since reporting the data initially, the database has continued to accrue cases and 
we have analysed the data to see if the previous findings have held and to see if there has 
been a change in the frequency of reported IN over time.  
2. Materials and methods 
The patient population, surgical and specimen handling process has been previously 
reported.(McCloskey et al. 2007) The population consists of patients referred to the Sexual 
Health Clinic at Royal Perth Hospital from December 1995 to December 2010. Anal or 
perianal warts were treated by scissor excision by a single sexual health physician if they 
were large or multiple or located within the anal canal by scissor excision. Patients who 
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were immunosuppressed or who had only mapping biopsies performed or whose HIV 
status was unknown were excluded from the main analysis. 
3. Data analysis 
Descriptive analysis used percentages for categorical and ordinal variables and means for 
continuous variables. Viral load and CD4 counts and percentages for HIV positive 
patients were found to follow a skewed log-normal distribution (Shapiro-Wilk’s test, p > 
0.05 for all variables) and the geometric mean was reported as an unbiased estimate of the 
mean. These variables were transformed using a natural logarithm for further analysis 
that was based upon an assumption of normality. For bivariable analysis of categorical 
and ordinal variables the likelihood ratio χ2 test was used. For these analyses with 
continuous variables the Wilcoxon rank-sum test was used. Multivariable linear logistic 
regression analysis was used to examine associations with HIV status and other 
dichotomous variables and ordinal logistic regression was used to examine associations 
with the degree of IN. The validity of these latter statistical models depends upon an 
assumption of proportional odds across the outcome categories and this was assessed 
using the Brant test(Brant 1990). In every case the analysis was found to be valid. The 
assumption of linearity for continuous independent variables was assessed using 
restricted cubic splines and where non-linearity was found a spline regression was used 
to model the association.(Harrell 2001)  Analysis of the degree of IN used operation as the 
unit of investigation and because operations are clustered within patients the assumption 
of independent sampling is violated. Estimates of standard error and p values were based 
upon a robust estimation of the clustered data. A p value less than 0.05 was regarded as 
statistically significant for all analysis. The analysis was conducted using the Stata 
statistical package (Version 11.1).(Corp 2009). 
4. Results 
4.1 Patient characteristics and operative procedures 
Removal of anal and/or perianal warts was performed during 461 operations in 343 
patients, 255 (74%) men and 88 (26%) women) of whom 278 (81%) of patients and 378 (82%) 
of operations were eligible to be included in the analysis. Reasons for exclusion included 
lack of histology results because of insufficient surgical material (total 44 patients, 30 men 
and 14 women), unknown HIV status (9 patients), operations performed for mapping 
biopsies (19 operations) and immunosuppression other than HIV (16 patients). In some 
instances there were multiple reasons for exclusion. Table 1.1 shows demographic data HIV 
antibody status for males, and Table 1.2 shows demographic data by HIV antibody status 
for females. Sixty-one eligible patients had HIV infection (59 men and two women). Men 
with HIV were significantly older than men without HIV (mean 8.7 years, 95% CI: 7.7-9.67, 
p<0.00001 rank sum test) (see Figure 1: Age distribution by HIV status).  
A spline regression analysis showed that the likelihood of being HIV positive increased non-
linearly with age in this population. The proportion positive increased at a significantly 
greater rate with each increasing year of age until about 30 years after which the proportion 
increases at a statistically significant but slower rate of increase (see Figure 2: HIV risk for 
men by age). 
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Graphs by HIV status, p < 0.00001, rank-sum test.  
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Fig. 2. HIV risk for men by age, results of a non-linear spline regression 
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Seventy-three percent of male patients were homosexual/bisexual, 27% heterosexual and 
47% current smokers. At the time of the first operation, the average duration of HIV 
infection was 3.4 years (95% CI: 2.4-5.0, geometric mean); the average CD4 T-cell count at 
first surgery was 329 x106/L (95% CI: 258–420 x106/L, geometric mean) and the average 
nadir CD4 T-cell count prior to surgery was 96 x106/L (95% CI: 66–139 x106/L, geometric 
mean). The HIV viral loads ranged from 40 to 135,000 viral copies/mL with 50% having a 
viral load less than 395, 25%, 395–20,400 and 15%, 20,400 –38,000). Sixty-four% of men 
without HIV were homosexual/bisexual, 36% heterosexual and 43.5% current smokers. The 
number of operations performed ranged from one to five for both HIV -positive men and 
HIV-negative men. 
4.2 Change over time 
Differences between the period December 1995-December 2004 and January 2005-December 
2010 shows that there has been significant change in the patient population in the period 
December 2004 to Jan 2005 compared to the previously reported period of 1995 to 2004 
(Table 2). Variables that show the change are age (3.0 years older, p=0.033), almost half as 
many (57% more) HIV infected patients (p =0.032), fewer homosexual (7% less) but more 
bisexual men (39% more), the number of lifetime partners is increased in males but not 
females, a greater proportion of patients have a history of chlamydia, there is less perianal 
disease and more anal disease. Importantly however between the two periods there has 
been no significant change in AIN or perianal intraepithelial neoplasia (PAIN). 
4.3 Rates of IN were highest in patients with HIV infection 
When all the operations are considered men with HIV infection and for whom 
histological data was available, 45 (44.1%) had AIN 2–3 (high-grade AIN) and 19 
(58.1%) had PAIN 2–3 (Table 3). Overall, men with HIV had some form of high-grade 
IN in 68 (57.8%), with 85 (78%) having any grade of abnormality (AIN or PAIN 1-3). 
HIV negative men had high-grade IN in 49 (24.7%), 25 (5.7%) had high-grade PAIN, and 
32 (21.4%) had high-grade AIN. The risk of IN was 2.9 times higher for HIV positive 
men than those without HIV for AIN (p<0.0001, ordinal logistic regression analysis) and 
4.0 times higher than men without HIV for PAIN (p<0.0001, ordinal logistic regression 
analysis). The rate of AIN 2-3 was 10.7% for HIV-negative women and 1.8% for PAIN. 
Except for a few perianal lesions with classical features of Bowen’s disease, none of  
the IN was evident at operation and was only discovered with histopathological 
examination.  
The rate of PAIN or AIN 2–3 was significantly higher 64.7% (66/36) for 
homosexual/bisexual men with HIV and 33.3% (45/90) in those without HIV infection 
(P<0.0001). The rate of IN was consistently higher in the anal canal compared with the 
perianal area (p < 0.00001) (Table 3.1 and 3.2). Table 4 shows this difference for all 
operations, the samples would fall diagonally in the table if there were no difference 
between anal and perianal samples (see Table  4). Of the patients with PAIN or AIN, there is 
a statistically significant interaction between HIV status and current smoking, with those 
who are HIV positive and current smokers being 6.0 times more likely to have a higher 
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 HIV positive 
n = 64 (%) 
HIV negative 
n = 153 (%) 
P 
Men 
Mean age (years) 40.4 30.1 <0.0001 
Range 22.9 – 71.8 13.7 – 71.7  
Sexual preference    
Heterosexual 3 (4.7) 55 (36.0) <0.001 
Homosexual 50 (78.1) 77 (50.3)  
Bisexual 11 (17.2) 21 (13.7)  
Lifetime Number of Sexual Partners   
1 - 10 4 (8.2) 32 (30.2) 0.002 
11 - 50 17 (34.7) 39 (36.8)  
>50 28 (57.1) 35 (33.0)  
Smoking status   0.445 
Current 34 (53.1) 67 (43.8)  
Ex-smoker 5 (7.8) 13 (8.5)  
Never smoked 25 (39.1) 73 (47.7)  
History of STDs    
Syphilis 8 (12.5) 4 (2.6) 0.006 
Gonorrhoea 20 (31.3) 14 (9.2) <0.001 
Chlamydia 9 (14.1) 18 (11.8) 0.643 
NSU 5 (7.8) 9 (5.9) 0.604 
History of genital herpes 17 (26.6) 12 (8.0) <0.001 
HSV-2  seropositive 22 (42.3) 20 (18.2) 0.001 
Hepatitis C antibody 
positive 
5 (8.8) 4 (3.1) 0.107 
Wart site first operation   
Perianal only 3 (4.7) 34 (22.2) <0.001 
Anal only 21 (32.8) 35 (22.98)  
Perianal & anal 38 (59.4) 74 (48.4)  
Perianal & penile 0 9 (5.9)  
Perianal, anal & penile 1 (0.7) 2 (3.1)  
Number of operations    
1 38 (59.4) 118 (77.1) 0.029 
2 13 (20.3) 26 (17.0)  
3 8 (12.5) 6 (3.9)  
4 4 (6.3) 2 (1.3)  
5 1 (1.6) 1 (0.7)  
 
Table 1.1. Demographic data by HIV antibody status for males 
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Women n = 2 n = 59  
Mean age (years) 22.2 27.4 0.352 
Range 19.5-25.4 16.9 -65.0  
Sexual preference   0.723 
Heterosexual 2 (100) 57 (96.6)  
Homosexual/bisexual 0 2 (3.4)  
Lifetime number of sexual partners  0.562 
1 - 10 2 (100) 32 (74.4)  
11 - 50 0 6 (14.0)  
>50 0 5 (11.6)  
Smoking status   0.160 
Current 0 31 (52.5)  
Ex-smoker 0 5 (8.5)  
Never smoked 2 (100) 23 (39.0)  
    
History of STDs    
Syphilis 0 0  
Gonorrhoea 1 (50.0) 3 (5.1) 0.081 
Chlamydia 1 (50.0) 5 (8.5) 0.138 
NSU 0 1 (1.7) 0.795 
History of genital herpes 0 3 (5.4) 0.642 
HSV-2 seropositive 0 4 (9.5)  
Hepatitis C Antibody 
positive 
0 0  
    
Wart site first operation   0.732 
Perianal only 0 11 (18.6)  
Anal only  0 4 (6.8)  
Perianal and anal 0 11 (18.6)  
Perianal, anal and  vulval 1 (50.0) 13 (22.0)  
Perianal and vulval 1 (50.0) 16 (27.1)  
    
Number of operations   0.138 
1 1 (50.0) 54 (91.5)  
2 1 (50.0) 5 (8.5)  
Table 1.2. Demographic data by sex and HIV antibody status for females 
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Age 3.04 0.25 5.84 0.033 




Heterosexual 0 (reference)  
Homosexual 0.93 0.26 1.59 0.006 




Heterosexual 0 (reference)  




Male 0.73 0.11 1.34 0.020 
Female -0.02 -1.37 1.33 0.976 
Smoking status  
Never 0 (reference)  
Current -0.41 -0.91 0.08 0.102 
Ex-smoker 0.28 -0.62 1.18 0.543 
History of:  
Syphilis  1.33 0.005 2.66 0.049 
Gonorrhoea 0.34 -0.35 1.03 0.332 
Chlamydia 1.00 0.23 1.76 0.011 
HSV2 -0.12 -.086 0.63 0.756 
NSU 0.06 -0.99 1.10 0.914 
Warts -1.90 -2.76 -1.04 <0.001 
HAV 0.26 -0.29 0.82 0.349 
HCV -0.33 -1.67 1.02 0.634 
HSV serology -0.50 -1.16 0.16 0.140 
Prior wart treatment -0.93 -1.41 -0.44 <0.001 
Number of operations -0.20 -0.41 0.00 0.051 
Site perianal -0.86 -1.38 -0.35 0.001 
Site anal 1.48 0.89 2.08 <0.001 
PAIN -0.23 -0.93 0.47 0.528 
AIN 0.17 -0.31 0.65 0.488 
IN 0.28 -0.19 0.74 0.246 
CD4 count at surgery 
(ln) 
-0.28 -0.76 0.21 0.262 
Viral load at surgery 
(ln) 
-1.63 -2.85 -0.41 0.010 
CD4 count at nadir (ln) -0.06 -0.35 0.23 0.681 








The data is consistent with our earlier observations of high rates of any IN men with HIV 
infection. Approximately 25% of HIV negative men had high-grade IN, indicating that 
anal/perianal warts in HIV negative men cannot be assumed to be benign lesions. 
Conversely anogenital warts in men with HIV have a high likelihood of containing some 
degree of IN with 62% having high-grade. The consistency of the data over the longer time 
period it highlights the importance of treating anal/perianal warts to remove IN that may 
eventually progress to invasive cancer as has previously been reported in the 
literature.(Scholefield, Castle and Watson 2005, Siegel 1962, Sturm et al. 1975) In particular 
the rates of anal cancer are rapidly rising in men with HIV(Crum-Cianflone et al. 2010) and 
it may be that men with warts represent a population of men at increased risk especially 
given the relatively common findings of anal cancer in men with warts (8.8%). Genital warts 
are recognised as a risk factor for the development of IN in renal transplant recipients.(Patel 
et al. 2010)  AIN has been reported to progress to anal cancer with 10% progression at 5 
years with higher rates in immunosuppressed individuals or those with multifocal 
disease.(Scholefield, Harris and Radcliffe 2011) Unlike other authors(Schlect et al. 2010) we 
did not detect anal cancer in any of the anal warts excised, but in our population, men with 
warts are referred early for surgery soon after the warts are diagnosed in the clinic. Schlect 
et al(Schlect et al. 2010) have similarly found high rates of IN in anal condylomata in 75/159 
(47%) HIV positive men. In particular, given the increasing rates of anal cancer in men 
(Daling et al. 1982, Goedert et al. 1998)with HIV, further studies to explore the role of ‘low-
risk’ HPV genotypes associated with warts and their possible role in anal cancer 
development should be undertaken. The fact that genotyping studies of anal cancer are 
 
Men   HIV positive   HIV negative      P 
Anal and/or perianal IN n= 109   n= 199 
None   24 (22.0)   112 (56.3)            <0.001 
IN 1   17 (15.6)   38 (19.1) 
IN 2   20 (18.4)   27 (13.6) 
IN 3   48 (44.0)   22 (11.1) 
Total IN   85 (78.0)   87 (43.7)    
 
Anal   n = 102   n = 150      
None   36 (35.3)    87 (58.0)             <0.001 
IN 1   21 (20.6)   31 (20.7) 
IN 2   20 (19.6)   22 (14.7) 
IN 3   25 (24.5)   10 (6.7) 
Total AIN  66 (64.7)    63 (42.0) 
Perianal   n=67   n=140             <0.001 
None   42 (61.2)   119 (85.0) 
IN 1   7 (10.5)    13 (9.3) 
IN 2   4 (6.0)   2 (1.4) 
IN 3   15 (22.4)    6 (4.3) 
Total IN   26 (38.8)   21 (15.0)   
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sometimes finding only HPV 6 indicate this ‘low –risk’ HPV genotype  may not in fact be 
‘low risk’ in the anal canal in men.(Hillman et al. 2010, Abramowitz et al. 2010)  Vaccination 
of boys to prevent infection of HPV with both low and high-risk HPV types should be 
promoted. 
 
Anal and/or perianal IN  
n = 3   n = 62 
None   2 (66.7)   45 (72.6)   0.308 
IN 1   0   12 (19.4) 
IN 2   0    1 (1.6) 
IN 3   1 (33.3)      4 (6.5) 
Total IN    1 (33.3)      17 (27.5)    
 
Anal   n = 1   n = 33    0.298 
None   0    17 (60.7) 
IN 1   0    8 (28.6) 
IN 2   0     0  
IN 3   1 (100)    3 (10.7) 
Total IN    1 (100)     11 (33.3)     
 
Perianal   n = 3   n = 56    0.088 
None   2 (66.7)   53 (94.6) 
IN 1   0   2 (3.6) 
IN 2   0    1 (1.8) 
IN 3   1 (50.0)      0  
Total IN   1 (50.0)     3 (5.4)     
Table 3.2 IN by HIV antibody status , and anatomical site- perianal/anal for all operations 
for females 
 
PAIN PAIN PAIN PAIN PAIN PAIN 
AIN Negative IN 1 IN 2 IN 3 Total 
Negative 86 3 1 1 91 
% 49.7 1.7 0.6 0.6 52.6 
IN 1 29 6 1 2 38 
% 16.8 3.5 0.6 1.2 22.0 
IN 2 17 6 3 0 26 
% 9.8 3.5 1.7 0.0 15.0 
IN 3 7 0 1 10 18 
% 4.1 0.0 0.6 5.85 9.7 
Total 139 15 6 13 173 
% 80.4 8.7 3.5 7.5 100.0 
Asymptotic symmetry test: χ2 = 46.4, d.f. = 6, p < 0.00001 
Table 4. Contrast of AIN and PAIN 
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